There is a wide range in the lipid levels among patients with FH, and this is largely related to the severity of the mutation and the specific gene; patients carrying a mutation in the LDLR gene, for example, tend to suffer from a more severe phenotype than APOB mutation carriers [4]. The gene discussed is LDLR; the disease is familial hyperaldosteronism.